Showing results (211-220 of 330) with videos related to

Sort By:
Pageof 33
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 1, 2006
Reduced serum levels of brain-derived neurotrophic factor in adult male patients with autismKenji Hashimoto, Yasuhide Iwata, Kazuhiko Nakamura, et al.
Neuroscience Research|June 14, 2003
A decrease in interleukin-1 receptor antagonist expression in the prefrontal cortex of schizophrenic patientsKazuhiko Toyooka, Yuichiro Watanabe, Shuji Iritani, et al.
Asian Journal of Psychiatry|November 19, 2021
Reliability and validity of the Japanese version of the 4A's Test for delirium screening in the elderly patientTadashi Hasegawa, Tomomi Seo, Yoko Kubota, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 6, 2020
Genetic risks of schizophrenia identified in a matched case-control studyKengo Oishi, Tomihisa Niitsu, Nobuhisa Kanahara, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|May 21, 2005
Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapyKeisuke Kobayashi, Eiji Shimizu, Kenji Hashimoto, et al.
The American Journal of Psychiatry|August 29, 2003
Association of dopamine transporter loss in the orbitofrontal and dorsolateral prefrontal cortices with methamphetamine-related psychiatric symptomsYoshimoto Sekine, Yoshio Minabe, Yasuomi Ouchi, et al.
Psychiatry and Clinical Neurosciences|July 2, 2009
Association between neuropeptide Y gene and its receptor Y1 gene and methamphetamine dependenceYuko Okahisa, Hiroshi Ujike, Tatsuya Kotaka, et al.
Annals of General Psychiatry|October 26, 2016
Effect of mirtazapine versus selective serotonin reuptake inhibitors on benzodiazepine use in patients with major depressive disorder: a pragmatic, multicenter, open-label, randomized, active-controlled, 24-week trialTasuku Hashimoto, Akihiro Shiina, Tadashi Hasegawa, et al.
Neuropsychiatric Disease and Treatment|December 18, 2015
Milnacipran treatment and potential biomarkers in depressed patients following an initial SSRI treatment failure: a prospective, open-label, 24-week studyTasuku Hashimoto, Daiji Sakurai, Yasunori Oda, et al.
Neuroscience Letters|May 26, 2004
Lack of association between angiotensin I-converting enzyme insertion/deletion gene functional polymorphism and panic disorder in humansEiji Shimizu, Kenji Hashimoto, Keisuke Kobayashi, et al.
Pageof 33